Creganna-Tactx Medical has opened a new office at Cleveland Clinic’s Global Cardiovascular Innovation Centre (GCIC) to support companies commercializing medical device technology.
Creganna-Tactx Medical develops less invasive devices for the top medical device OEM’s and is a global contract design and outsourced manufacturing companies.
The GCIC, located on Cleveland Clinic’s main campus, is an incubator facility supporting the development and commercialization of cardiovascular innovations and medical technologies.
The office will provide product development support to early stage companies and also link Creganna-Tactx’s customers to the leaders in medical innovation and healthcare delivery.
The new office can facilitate connections to physicians and provide its customers with enhanced design and development support, end-user feedback, device testing and support for pre-clinical studies and clinical trials.
The service will be further bolstered by the company’s recent joint venture agreement with Boston Biomedical Associates (BBA), who will work in partnership with Creganna-Tactx Medical to support customers with clinical, regulatory and quality affairs.
Cleveland Clinic Innovations executive director Chris Coburn said having Creganna-Tactx Medical as part of the Clinic team is an important milestone for them.
"They will provide benefit to GCIC companies and will collaborate with Clinic innovators as we jointly work to develop products that benefit patients in need," Coburn said.